CXI Healthcare Technology Group씨엑스아이
900120 · KOSDAQ · ₩900120 · 씨엑스아이
₩2,995▼ ₩235 (7.28%)End-of-day · Oct 26, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩297M | ₩377M | ₩377M | ₩545M | ₩610M |
| Cost of sales | ₩208M | ₩215M | ₩229M | ₩393M | ₩483M |
| Gross profit | ₩89M | ₩162M | ₩149M | ₩153M | ₩127M |
| Operating income | ₩50M | ₩102M | ₩38M | ₩34M | ₩26M |
| Net income | ₩66M | ₩159M | ₩40M | ₩32M | ₩30M |
| Net income to shareholders | ₩66M | ₩159M | ₩40M | ₩32M | ₩30M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩2.6B | ₩2.5B | ₩2.3B | ₩2.2B | ₩2.2B |
| Current assets | ₩1.2B | ₩983M | ₩670M | ₩518M | ₩362M |
| Cash and equivalents | ₩1.1B | ₩840M | ₩523M | ₩341M | ₩148M |
| Total liabilities | ₩13M | ₩14M | ₩19M | ₩47M | ₩74M |
| Current liabilities | ₩10M | ₩13M | ₩15M | ₩45M | ₩72M |
| Borrowings | ₩2.3M | ₩344,718 | ₩4.5M | ₩0 | ₩3.5M |
| Total equity | ₩2.6B | ₩2.5B | ₩2.3B | ₩2.2B | ₩2.1B |
| Shareholders' equity | ₩2.6B | ₩2.5B | ₩2.3B | ₩2.2B | ₩2.1B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | — | — | — | ₩187M | ₩50M |
| Capital spending | — | — | — | ₩0 | ₩0 |
| Free cash flow | — | — | — | ₩187M | ₩50M |
Consolidated where available. Amounts in won.
Also known as: CXI Healthcare Technology Group / 씨엑스아이 / 900120 / KRX:900120
Source: KRX statistical information